Skip to main content
logo
Ryvu Therapeutics S.A. (FRA:9Y4)
Germany flag Germany · Delayed Price · Currency is EUR
6.43
+0.04 (0.63%)
Last updated: Jan 9, 2026, 9:12 AM CET

Revenue by Product

Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192014 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2014 - 2018
Novel Small Molecule Therapies
46.86M
Log In
Log In
Log In
Log In
Upgrade
Novel Small Molecule Therapies Growth
20.32%
Log In
Log In
Log In
Log In
Upgrade
Service
-
Log In
Log In
Log In
Log In
Upgrade
Service Growth
-
Log In
Log In
Log In
Log In
Upgrade
Bioinformatics
-
Log In
Log In
Log In
Log In
Upgrade
Bioinformatics Growth
-
Log In
Log In
Log In
Log In
Upgrade
Exclusion Income between Segments
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192014 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2014 - 2018
European Union Countries
41.66M
Log In
Log In
Log In
Log In
Upgrade
European Union Countries Growth
69.25%
Log In
Log In
Log In
Log In
Upgrade
Other Countries
5.16M
Log In
Log In
Log In
Log In
Upgrade
Other Countries Growth
-63.73%
Log In
Log In
Log In
Log In
Upgrade
Poland
38.00K
Log In
Log In
Log In
Log In
Upgrade
Poland Growth
-64.15%
Log In
Log In
Log In
Log In
Upgrade
United States
-
Log In
Log In
Log In
Log In
Upgrade